NCT02446574View on ClinicalTrials.gov

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Esophageal Neoplasms
Interventions
DRUG

Paclitaxel

starting dose 20mg/m2 qw

DRUG

Cisplatin

dose 25mg/m2 qw

RADIATION

Radiation

60Gy/2Gy/30f

Trial Locations (1)

100021

Cancer Institute and Hospital, Chinese Academy of Medical Science, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT02446574 - Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter